Bekleidet derzeit Positionen bei Oscient Pharmaceuticals Corp, Tekla Life Sciences Investors, abrdn Healthcare Investors, abrdn World Healthcare Fund and abrdn Healthcare Opportunities Fund
| 30 Tage | 90 Tage | 120 Tage | |
|---|---|---|---|
| Durchschnittliche Rendite | 9% | 8.2% | 15.1% |
| Erfolgsquote | 80% | 68% | 82% |
| Transaktionen |
6
100% Kauf
|
34
71% Kauf
|
47
69% Kauf
|
| Position | Unternehmen | Zeitraum |
|---|---|---|
| Director | Oscient Pharmaceuticals Corp | 19. März 2003 - |
| Independent Trustee | Tekla Life Sciences Investors | 1. Januar 2010 - |
| Independent Trustee | abrdn Healthcare Investors | 8. Juni 2010 - |
| Independent Trustee | abrdn World Healthcare Fund | 1. Januar 2015 - |
| Independent Trustees | abrdn Healthcare Opportunities Fund | 1. Januar 2014 - |
| Lead Independent Director | Idera Pharmaceuticals Inc | 1. September 2010 - 10. März 2019 |
| Independent Director | Madrigal Pharmaceuticals, Inc. | 1. August 2004 - 22. Juli 2016 |